ArticleNeurocritical care2026
Optimal Transfusion Thresholds in Patients with Acute Brain Injury: A Bayesian Network Meta-analysis of Randomized Controlled Trials.
Article in Neurocritical care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundThe optimal transfusion threshold for acute brain injury (ABI) remains uncertain. Previous studies comparing liberal and restrictive transfusion strategies have yielded inconsistent findings. Therefore, we performed a Bayesian network meta-analysis to compare the effectiveness and safety of different transfusion thresholds in patients with ABI.
methodsA systematic search of PubMed, Embase, Medical Literature Analysis and Retrieval System Online (MEDLINE), and the Cochrane Library was performed to identify randomized controlled trials (RCTs) comparing red blood cell transfusion thresholds in patients with ABI. The primary outcomes were mortality and unfavorable functional outcome. Risk ratios (RRs) with 95% credible intervals (CrIs) were estimated from the Bayesian network meta-analysis, and treatment rankings were assessed using the surface under the cumulative ranking curve (SUCRA).
resultsSix RCTs involving 2599 patients were included. Four transfusion thresholds were evaluated (hemoglobin levels of 7, 8, 9, and 10 g/dL). Compared with a transfusion threshold of 7 g/dL, a threshold of 9 g/dL was associated with a lower risk of unfavorable functional outcome (RR 0.86, 95% CrI 0.78-0.94; direct evidence from two trials). Compared with 8 g/dL, the estimated effect favored a 9 g/dL threshold, but the evidence was indirect and did not reach statistical significance (RR 0.79, 95% CrI 0.63-1.00). No clear differences in adverse events were observed across the evaluated thresholds. The 9 g/dL threshold ranked highest according to SUCRA values for both mortality and neurological outcomes. Meta-regression analysis suggested that baseline hemoglobin level may represent a potential source of heterogeneity in the effect of liberal transfusion strategies on functional outcomes.
conclusionsAmong the evaluated transfusion thresholds, a threshold of 9 g/dL ranked most favorably for functional outcome and was associated with a lower risk of unfavorable functional outcome than 7 g/dL, without clear differences in mortality, infectious complications, or thromboembolic events.
Indexed as
Identifiers
42864514What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.